Supplements for Longevity and Cognition: Ranked by Evidence

Supplements can matter after 40, but they are rarely the first-order answer. The highest-confidence stack is still aerobic fitness, muscle preservation, sleep, blood-pressure control, metabolic health, and recovery. This guide ranks the supplement categories on Timeless Wisdom by evidence so readers can see what deserves serious attention, what belongs in the “interesting but uncertain” bucket, and what should stay out of a default stack.

How to use this guide

• Best evidence: Omega-3 for selected cardiometabolic use cases, CoQ10 in some cardiovascular contexts, and berberine when glucose or lipid management is the real problem.
• Best for: Adults 40+ who want a supplement map ranked by certainty rather than by novelty.
• Highest uncertainty: NMN / NAD+ boosters for healthy aging, ergothioneine as a longevity default, and specialty nootropics such as huperzine A or racetams for healthy adults.

Supplements ranked by evidence, not by internet buzz

Supplement	Evidence level	Best for	Main risk or limitation
Omega-3	Moderate	Triglycerides, cardiometabolic support, and selected aging contexts	Cognition and direct longevity claims remain softer than the marketing
Berberine	Moderate	Glucose control, insulin-resistance contexts, and selected lipid endpoints	GI side effects, drug interactions, and weak logic for using it without a metabolic reason
CoQ10	Moderate	Selected cardiovascular settings and some statin-related use cases	General healthy-aging use is much less established than heart-related contexts
Taurine	Emerging	Cardiometabolic markers and selected recovery or fatigue discussions	Interesting human data exist, but long-term healthy-aging benefit is still unproven
NMN / NAD+ boosters	Emerging	Biomarker-focused experimentation for readers who understand the uncertainty	Small trials, short follow-up, cost, and no proven human longevity outcome
Ergothioneine	Emerging	Mechanistically interesting antioxidant and cognition-focused monitoring	Human intervention evidence is still thin and not enough for routine use
Resveratrol	Speculative	Mechanism-driven interest more than dependable real-world outcomes	Translation from theory to useful human results has remained underwhelming
Huperzine A, racetams, and hard nootropics	Speculative	Niche, case-specific discussions rather than a general stack for healthy adults 40+	Condition-specific evidence, regulatory ambiguity, and a high risk of overstated claims

What belongs in the top tier

The highest-confidence supplement lane is narrower than most longevity blogs admit. Omega-3 belongs here when the use case is cardiometabolic support or low intake of oily fish. Berberine belongs here when someone actually has glucose or insulin-resistance issues to solve. CoQ10 belongs here mainly in cardiovascular contexts or where statin use makes the question more relevant. None of these compounds outrank training, sleep, or metabolic basics, but at least they have a real clinical lane.

What belongs in the middle tier

Taurine, NMN, broader NAD+ boosters, and ergothioneine are better viewed as monitored experiments than as default recommendations. The biology is interesting. Some human data exist. But the jump from biomarker changes or small trials to reliable long-term benefit is still too large for certainty. These compounds deserve curiosity and restraint at the same time.

What belongs in the speculative tier

Resveratrol and specialty nootropics such as huperzine A or racetams attract a lot of attention because the mechanisms sound impressive. That is exactly why they need the highest bar. A mechanism is not a clinical outcome, and disease-specific or poorly standardized evidence should not be generalized into a healthy-adult longevity stack.

How to decide whether a supplement has earned a place in your stack

• Start with the use case. If you cannot name the real problem you are trying to solve, the supplement has not earned a place yet.
• Check the evidence type. Human randomized trials and systematic reviews deserve more weight than mechanistic enthusiasm.
• Surface the downside. Interactions, cost, product quality, and monitoring burden belong in the decision.
• Compare it with the basics. If sleep, training, blood pressure, protein intake, or waistline control are weak, fix those before adding a speculative compound.

Key evidence sources

• Effect of omega-3 fatty acids on cardiovascular outcomes: a systematic review and meta-analysis
• Effect of coenzyme Q10 on cardiac function and survival in heart failure: an overview of systematic reviews and meta-analyses
• Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis
• Effects of Oral Taurine Supplementation on Cardiometabolic Risk Factors: a meta-analysis and systematic review of randomized clinical trials
• Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
• Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: a pilot study

Related guides

• Best Evidence-Backed Longevity Interventions After 40
• Omega-3 Benefits: Boosting Cognition, Muscle and Longevity
• Discover the Benefits of CoQ10 for Healthy Aging and Heart Health
• Natural Power: Berberine and Apple Cider Vinegar for Better Health
• Taurine Discoveries: Latest Research and Health Benefits
• Discover the Health Benefits of Ergothioneine
• Discovering the Benefits of NMN: From Anti-Aging to Energy Boosting
• Boosting Your Sirtuins: Strategies for NAD+ Modulation
• The Controversy Surrounding Resveratrol

Next step: Use the broader longevity decision map to decide whether you even need a supplement intervention, then go deeper on the one or two compounds that match a real use case instead of building a novelty stack.